HHS News header image

This is an archive page. The links are no longer being updated.

FOR IMMEDIATE RELEASE
Friday, April 7, 2000
Contact: HRSA Press Office
(301) 443-1745

FEDERAL PROGRAM PUTS HIGH-COST AIDS MEDICATIONS
WITHIN REACH OF POOR AND UNINSURED PEOPLE


HHS Secretary Donna E. Shalala today announced the award of $794 million in grants to 50 states, the District of Columbia and U.S. territories to improve access to HIV/AIDS primary care, support services and medications for people living with HIV/AIDS and their families. This amount includes nearly $528 million earmarked for state AIDS Drug Assistance Programs (ADAP), which provide financial assistance to purchase HIV medications.

The grants will provide more than 78,000 low-income, HIV-positive people with access to life-saving medications each month.

"This Administration has responded aggressively to the threat posed by HIV/AIDS, with increased attention to research, prevention and treatment," Secretary Shalala said. "For many Americans, these grants are a lifesaver, helping provide new drug therapies to those who can least afford them."

"In working together, we must use all our resources to fight HIV/AIDS. The Ryan-White program has proven to be a critical tool in our fight against this disease," said Surgeon General David Satcher. "We must continue to work to educate, motivate, and mobilize our communities to prevent the spread of HIV, and care for those living with the disease. AIDS impacts everyone."

The grants are funded under Title II of the Ryan White Comprehensive AIDS Resources Emergency (CARE) Act, which provides HIV/AIDS care to low-income, uninsured and underinsured individuals affected by the epidemic. The CARE Act is administered by HHS' Health Resources and Services Administration (HRSA).

Title II formula grants are based on a calculation of the estimated number of people living with AIDS in the state or territory. Since fiscal year 1996, separate funds have been earmarked under Title II to support state ADAPs in purchasing drugs for people living with HIV/AIDS. States also may designate a portion of their Title II formula grant to support ADAPs. In 1999, states estimated that approximately 108,600 individuals with HIV disease-with limited or no coverage from private insurance or Medicaid-accessed ADAPs.

"Increased funding specifically for the AIDS Drug Assistance Program reflects the significant technological advances in HIV/AIDS treatment in the last 10 years," said Health Resources and Services Administration Administrator Claude Earl Fox, M.D. M.P.H. "The grants announced today will go a long way in getting powerful combination drug therapies, primary care and support services to people with HIV disease."

Since the CARE Act was first funded in fiscal year 1991, some $3.3 billion in Title II grants have been awarded. States have received close to $1.5 billion in earmarked ADAP funds since fiscal year 1996.

The grants are funded under Title II of the CARE Act, which is administered by the Health Resources and Services Administration through its HIV/AIDS Bureau. The CARE Act was enacted in 1990 to help poor and uninsured individuals with HIV/AIDS get primary care, support services and life-sustaining medications.

Click here -- www.hhs.gov/news/press/2000pres/20000407.pdf -- for a list of fiscal year 2000 Title II and ADAP grant awards.

###


Note: For other HHS Press Releases and Fact Sheets pertaining to the subject of this announcement, please visit our Press Release and Fact Sheet search engine at: www.os.dhhs.gov/news/press/